Stockscreener 앱 받기
1.4388
5.96%
-0.0912
시간 외 거래:
1.43
-0.0088
-0.61%
Silexion Therapeutics Corp 주식(SLXN)의 최신 뉴스
Tangible book value per share of Silexion Therapeutics Corp – NASDAQ:SLXNW - TradingView
SLXNW Financials: Income Statement, Balance Sheet & Cash Flow | Silexion Therapeutics Corp - Stock Titan
Silexion Therapeutics Corp: Clinical-Stage KRAS Oncology Innovations and siRNA Pipeline for Pancreatic Cancer - Minichart
Silexion Therapeutics Reports 2025 Financial Results and Clinical Program Updates - geneonline.com
Biotech Silexion lines up 2026 pancreatic cancer trial after $18.6M cash raise - Stock Titan
Silexion Therapeutics 10-K: $11.9M net loss, cash $6.08M; operating loss $11.63M - TradingView
Silexion Therapeutics (NASDAQ: SLXN) outlines SIL204 KRAS cancer strategy in 10-K - Stock Titan
Silexion Therapeutics Corp Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Growth Recap: Is Silexion Therapeutics Corp Equity Warrant a potential multi baggerTrade Volume Report & Long-Term Capital Growth Ideas - baoquankhu1.vn
Setup Watch: Can Silexion Therapeutics Corp Equity Warrant stock outperform in a bear marketBreakout Watch & Entry Point Confirmation Signals - baoquankhu1.vn
SLXN SEC FilingsSilexion Therapeutics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Are Bullish on Top Healthcare Stocks: MetaVia (MTVA), Immunome (IMNM) - The Globe and Mail
Fed Meeting: Can Silexion Therapeutics Corp Equity Warrant reach resistance levels soonQuarterly Profit Summary & Fast Gain Stock Trading Tips - baoquankhu1.vn
Silexion Therapeutics Urges Shareholders to Vote Ahead of March 16 Extraordinary General Meeting - Bitget
Silexion Therapeutics urges shareholders to vote ahead of EGM - TipRanks
Rally Mode: Is Silexion Therapeutics Corp a defensive stock2025 Price Targets & Entry and Exit Point Strategies - baoquankhu1.vn
SLXN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Book value per share of Silexion Therapeutics Corp – NASDAQ:SLXNW - TradingView
EPS Watch: Is First Light Acquisition Group Inc Equity Warrant vulnerable to short sellersQuarterly Portfolio Report & Smart Allocation Stock Tips - baoquankhu1.vn
SLXN Should I Buy - Intellectia AI
EBITDA per share of Silexion Therapeutics Corp – NASDAQ:SLXNW - TradingView
Market Fear: Should value investors consider CompoSecure Inc Equity WarrantMarket Activity Report & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Equity grants to director-linked fund at Silexion Therapeutics (SLXN) disclosed - Stock Titan
Director Alon Ruth receives Silexion (SLXN) share and stock option grants - Stock Titan
Silexion Therapeutics (SLXN) CFO receives 49,726-share equity grant - Stock Titan
Silexion (SLXN) CEO Hadar Ilan receives 64,350-share equity award - Stock Titan
Director at Silexion Therapeutics (SLXN) receives new share and option grants - Stock Titan
Silexion Therapeutics (SLXN) director granted 7,576 shares and 8,904 options - Stock Titan
Guangzhou Sino-Israel Biotech Fund gains SLXN equity for board service - Stock Titan
Ideas Watch: Is Olympic Steel Inc forming a breakout patternOptions Play & Weekly High Conviction Trade Ideas - baoquankhu1.vn
SLXNSilexion Therapeutics Corp Latest Stock News & Market Updates - Stock Titan
Will Silexion Therapeutics Corp benefit from geopolitical trendsDip Buying & AI Powered Buy/Sell Recommendations - mfd.ru
Can Silexion Therapeutics Corp Equity Warrant reach resistance levels soonWeekly Trend Recap & Expert Verified Movement Alerts - mfd.ru
Price Action: How volatile is Silexion Therapeutics Corp stockBull Run & Weekly Return Optimization Plans - baoquankhu1.vn
Silexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN) By FinanceWire - Investing.com
Silexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN) - TipRanks
Stock Report: Is Silexion Therapeutics Corp Equity Warrant stock forming a triangle patternWall Street Watch & Community Shared Stock Ideas - mfd.ru
Can Silexion Therapeutics Corp Equity Warrant stock deliver strong Q4 earningsQuarterly Portfolio Report & AI Enhanced Market Trend Forecasts - mfd.ru
S P Trends: Will CIMPRD benefit from rate cuts2025 Price Momentum & Daily Price Action Insights - baoquankhu1.vn
Momentum Shift: Should I hold or sell Silexion Therapeutics Corp now2025 Trading Volume Trends & Fast Gain Swing Alerts - baoquankhu1.vn
Can Silexion Therapeutics Corp sustain its profitability2025 Big Picture & Proven Capital Preservation Methods - mfd.ru
What’s the beta of Silexion Therapeutics Corp Equity Warrant stockJuly 2025 Highlights & Daily Risk Controlled Trade Plans - mfd.ru
Is Silexion Therapeutics Corp stock affected by interest rate hikesMarket Activity Recap & Fast Gain Stock Tips - mfd.ru
What’s the profit margin of Silexion Therapeutics CorpAnalyst Upgrade & Safe Entry Trade Reports - mfd.ru
Trading Recap: Will Silexion Therapeutics Corp Equity Warrant benefit from government policyQuarterly Trade Report & Short-Term High Return Strategies - baoquankhu1.vn
Analyst Downgrade: Can Silexion Therapeutics Corp be recession proofMarket Trend Summary & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Silexion Highlights SIL204 RNAi Pancreatic Cancer Program Progress - TipRanks
Silexion Therapeutics Corp Prepares Investor Presentation on SIL204 - TradingView
Jobs Data: What is ALBTs P E ratio telling us2025 Sector Review & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Swing Trade: What is the earnings history of Claritev Corporation2025 Big Picture & Fast Momentum Entry Tips - baoquankhu1.vn
Aug Opening: Will Silexion Therapeutics Corp Equity Warrant benefit from government policyQuarterly Profit Summary & Expert Approved Trade Ideas - baoquankhu1.vn
Gap Down: Can Silexion Therapeutics Corp be recession proofQuarterly Risk Review & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Risk Hedge: Can Spring Valley Acquisition Corp II Equity Warrant sustain its profitability2025 Biggest Moves & Reliable Entry Point Alerts - baoquankhu1.vn
Investment Review: Can Silexion Therapeutics Corp Equity Warrant expand its profit marginsQuarterly Performance Summary & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Silexion shares skyrocket 400% after encouraging pancreatic cancer drug results - MSN
Growth Value: What is the implied volatility of Silexion Therapeutics Corp2025 Biggest Moves & High Win Rate Trade Alerts - baoquankhu1.vn
Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit - manilatimes.net
Silexion Therapeutics to Participate in 7th RNAi-Based Therapeutics Summit Focused on Advancing SIL204 for Pancreatic Cancer - Quiver Quantitative
Retail Surge: Whats the RSI of Kirby Corporation stock2025 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
1.20%
0.06%
자본화:
|
볼륨(24시간):